奥麦罗制药

OMER NASDAQ
20.70
+1.08
+5.50%
交易中 14:46 08/19 EDT
开盘
19.82
昨收
19.62
最高
20.77
最低
19.70
成交量
44.54万
成交均量(3M)
43.15万
52周最高
27.00
52周最低
10.30
换手率
0.90%
市值
10.20亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供奥麦罗制药 OMER股票价格,奥麦罗制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Omeros Corporation is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system. The Company’s drug product OMIDRIA (phenylephrine and ketorolac intraocular solution) is used during cataract surgery or intraocular lens (IOL) replacement. The Company’s clinical-stage development programs are focused on complement-associated thrombotic microangiopathies, complement-mediated glomerulonephropathies, Huntington’s disease and cognitive impairment, and addictive and compulsive disorders. It also offers a diverse group of preclinical programs and platforms that are used to unlock new G protein-coupled receptor (GPCR) drug targets and to generate antibodies.
展开 >

最近浏览

名称
价格
涨跌幅